An opportunity to focus not only on research, but the treatment options now available to women
The shocking truth about how pharmaceutical companies hired ghostwriters to distort results.
Dr Dach scrutinises the evidence on bio-identical hormones and their safety in the first of a 3 part series.
Dr Dach reveals how pharmaceutical companies are paying ghost writers to produce medical articles for publication that attempt to convince doctors to prescribe synthetic hormones instead of bioidenticals.
If you want to know more about the medical research into bioidentical hormones, then start here.
Dr Bond explains this common phenomenon, its causes and consequences.
A study undertaken in 2009 at Stanford University in California found that women who take HRT for more than five years double their risk of suffering breast cancer for every 12 months they spend taking it.
The jury made this award on the basis that the company, Wyeth, failed to warn about the risks of the drug and took only minutes to come to their decision.
A Danish government report has confirmed that chemicals such as PVC, flame retardants, phthalates, dioxins, PCBs and bisphenol-A are probably continuing to contribute to the birth of fewer males and the feminization of existing ones.
On 15 March, 2010 Pfizer announced that they have stopped a phase-III trial of their monoclonal antibody Figitumumab and two trials of Sunitinib in breast cancer after they failed to show significant improvement in survival rates.